Review
Open access
Sep 2026
Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases
Respiratory infections remain a major global health burden despite advances in systemic antimicrobial therapy. Antimicrobial dry powder inhalers (DPIs) have emerged as precision-engineered pulmonary delivery platforms capable of achieving high local drug concentrations while minimizing systemic toxicity. This review ex...
Hasham Shafi, David Encinas-Basurto, Y. Di et al.
· Lung · 0 citations